dipyridamole has been researched along with Coronary Occlusion in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Coronary Occlusion: Complete blockage of blood flow through one of the CORONARY ARTERIES, usually from CORONARY ATHEROSCLEROSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| VINEBERG, AM | 2 |
| CHARI, RS | 2 |
| PIFARRE, R | 2 |
| MERCIER, C | 2 |
2 other studies available for dipyridamole and Coronary Occlusion
| Article | Year |
|---|---|
The effect of persantin on intercoronary collateral circulation and survival during gradual experimental coronary occlusion. A preliminary report.
Topics: Animals; Collateral Circulation; Coronary Circulation; Coronary Disease; Coronary Occlusion; Coronar | 1962 |
[Effect of persantin on intercoronary collateral circulation and on survival obtained during progressive coronary occlusion in in animals. Preliminary report].
Topics: Animals; Blood Circulation; Collateral Circulation; Coronary Disease; Coronary Occlusion; Coronary V | 1962 |